Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06155643 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EKO SENSORA: Detecting Clinically Significant Murmurs

Study acronym: EkoNM
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Jul 26, 2026 to Jul 26, 2027
    • Site contact updated
    v6
  2. Notable Phase: Early Phase 1 to Not applicable
    • Primary and study completion dates: Jul 26, 2025 to Jul 26, 2026
    • Site contact updated
    v5
  3. Notable Primary and study completion dates: May 30, 2024 to Jul 26, 2025v4
  4. Minor Primary and study completion dates: Jan 30, 2024 to May 30, 2024v3
  5. Minor Eligibility criteria expanded, about 2 wordsv2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023). The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction. The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.
Trial Details
NCT Number NCT06155643
Lead Sponsor Corewell Health South
Conditions
(from sponsor)
Heart Murmurs
Related terms Heart Murmurs
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov